AUROBINDO PHARMA
Back to All Ratios
|
AUROBINDO PHARMA Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| CEPS(Rs) | 90.93 | 88.38 | 80.06 | 54.14 | 64.41 |
What is the latest Cash Earnings per Share (CEPS) ratio of AUROBINDO PHARMA ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2026 | 90.93 |
| Mar2025 | 88.38 |
| Mar2024 | 80.06 |
| Mar2023 | 54.14 |
| Mar2022 | 64.41 |
How is Cash Earnings per Share (CEPS) of AUROBINDO PHARMA Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2026 | 90.93 | 2.89 | |
| Mar2025 | 88.38 | 10.39 | |
| Mar2024 | 80.06 | 47.88 | |
| Mar2023 | 54.14 | -15.94 | |
| Mar2022 | 64.41 | - | |
Other Financial Ratios of AUROBINDO PHARMA
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹96,379.5 Cr | -2.1% | -0.5% | 51.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -2.1% |
-0.5% |
51.9% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses